Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI A Prespecified TWILIGHT Substudy

Chiarito, M., Baber, U., Cao, D., Sharma, S. K., Dangas, G., Angiolillo, D. J., Briguori, C., Cohen, D. J., Dudek, D., Džavík, V., Escaned, J., Gil, R., Hamm, C. W., Henry, T., Huber, K., Kastrati, A., Kaul, U., Kornowski, R., Krucoff, M., … Mehran, R. (2022). Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI. JACC: Cardiovascular Interventions, 15(3), 282–293. https://doi.org/10.1016/j.jcin.2021.11.005
Authors:
Mauro Chiarito
Usman Baber
Davide Cao
Samin K. Sharma
George Dangas
Samantha Sartori
Roxana Mehran
Giulio Stefanini
Dominick J. Angiolillo
Carlo Briguori
David J. Cohen
Dariusz Dudek
Vladimir Dzavik
Javier Escaned
Robert Gil
Christian W. Hamm
Timothy Henry
Kurt Huber
Adnan Kastrati
Upendra Kaul
Ran Kornowski
Mitchell Krucoff
E. Magnus Ohman
Vijay Kunadian
Shamir R. Mehta
David Moliterno
Keith Oldroyd
Gennaro Sardella
P. Gabriel Steg
Giora Weisz
Richard Shlofmitz
Bernhard Witzenbichler
Ya-Ling Han
Stuart Pocock
C. Michael Gibson
Affiliated Authors:
Giora Weisz
Columbia Affiliation:
Author Keywords:
drug-eluting stent(s)
percutaneous coronary intervention
prior myocardial infarction
ticagrelor
aspirin
elink
Publication Type:
Article
Unique ID:
10.1016/j.jcin.2021.11.005
PMID:
35033468
DOI:
10.1016/j.jcin.2021.11.005
Journal:
JACC: Cardiovascular Interventions
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: